The Vernal Capital Acquisition IPO launched after the company priced its public offering at $100 million on 5 May 2026. The special purpose acquisition company confirmed that it issued 10,000,000 units at $10.00 each. Moreover, the units are expected to begin trading on the New York Stock Exchange under...
There is something deceptively understated about this AI-first C-suite transformation. Beneath the polished optimism of corporate press releases lies...
Sun Pharma acquires Organon in a definitive all-cash agreement that significantly reshapes the global pharmaceutical landscape. The transaction values...
The Trident Resources option agreement marks a significant step in strengthening the company’s exploration footprint within Saskatchewan’s prolific La...